MLAB Mesa Laboratories Inc

  1. Stocks
  2. Technology
  3. NASDAQ: MLAB

Price (delayed)

$108.44

Market cap

$599.12M

P/E Ratio

88.89

Dividend/share

$0.64

EPS

$1.22

Enterprise value

$723.68M

?
Relative Growth: Rel. Growth: 93
Relative Strength: Rel. Strength: 76
Relative Valuation: Rel. Valuation: 62
Relative Profitability: Rel. Profitability: 74

Mesa Labs is a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, medical device, industrial safety, environmental, and food and beverage industries. ...

Highlights
The company's EPS has surged by 82% QoQ
Mesa Laboratories's net income has surged by 80% QoQ
The company's quick ratio has surged by 174% YoY but it fell by 9% QoQ
Sector: Technology
Industry: Scientific & Technical Instruments
Website: http://www.mesalabs.com
Peers: TMO HBIO AME STE

Key stats

What are the main financial stats of MLAB

MLAB stock price

How has the Mesa Laboratories stock price performed over time
Intraday
3.89%
1 week
5.18%
1 month
5.29%
1 year
7.44%
YTD
38.14%
QTD
22.64%

Financial performance

How have Mesa Laboratories's revenue and profit performed over time
Revenue
$249.13M
Gross profit
$158.27M
Operating income
$18.51M
Net income
$6.71M
Gross margin
63.5%
Net margin
2.7%
The net margin has soared by 80% from the previous quarter
Mesa Laboratories's net income has surged by 80% QoQ
MLAB's operating income is up by 13% YoY and by 7% from the previous quarter
The operating margin has grown by 9% YoY and by 6% from the previous quarter

Price vs fundamentals

How does MLAB's price correlate with its fundamentals

Growth

What is Mesa Laboratories's growth rate over time

Valuation

What is Mesa Laboratories stock price valuation
MLAB P/E details
P/E
88.89
P/B
3.22
P/S
2.4
EV/EBIT
31.87
EV/EBITDA
15.74
EV/Sales
2.9
The company's EPS has surged by 82% QoQ
MLAB's price to book (P/B) is 24% more than its last 4 quarters average of 2.5 and 3.3% more than its 5-year quarterly average of 3.0
MLAB's equity is up by 17% year-on-year
The P/S is 46% below the 5-year quarterly average of 4.3 but 28% above the last 4 quarters average of 1.8
MLAB's revenue is up by 3.4% year-on-year

Efficiency

How efficient is Mesa Laboratories business performance
The return on assets has surged by 78% since the previous quarter
MLAB's return on equity has surged by 76% since the previous quarter
The company's return on sales rose by 23% YoY but it fell by 9% QoQ
Mesa Laboratories's return on invested capital has decreased by 16% QoQ but it has increased by 14% YoY

Dividends

What is MLAB's dividend history
Dividend details
DPS
$0.64
Dividend yield
0.59%
Payout ratio
52.5%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Mesa Laboratories financials performed over time
Mesa Laboratories's total assets is 77% more than its total liabilities
The company's quick ratio has surged by 174% YoY but it fell by 9% QoQ
MLAB's current ratio has surged by 173% year-on-year but it is down by 11% since the previous quarter
The debt is 19% less than the equity
MLAB's debt to equity is down by 27% YoY and by 9% QoQ
MLAB's equity is up by 17% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.